hydroxycotinine has been researched along with Smoking Cessation in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 17 (65.38) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Flitter, A; Lerman, C; Schnoll, RA; Siegel, SD | 1 |
| Benowitz, NL; Chenoweth, MJ; El-Boraie, A; Fukunaga, K; Knight, J; Kubo, M; Lerman, C; Mushiroda, T; Nollen, NL; Pouget, JG; Sanderson Cox, L; Tyndale, RF | 1 |
| Cornuz, J; Csajka, C; Dobrinas, M; Eap, CB; Gholamrezaee, M; Glatard, A; Lubomirov, R | 1 |
| Benowitz, NL; Delucchi, KL; Hall, SM; Hendricks, PS | 1 |
| Chenoweth, MJ; Cinciripini, PM; George, TP; Hawk, LW; Lerman, C; Novalen, M; Schnoll, RA; Tyndale, RF | 1 |
| Benowitz, NL; Cinciripini, P; George, TP; Hawk, LW; Heitjan, DF; Lerman, C; Schnoll, RA; Swan, GE; Tyndale, RF; Wileyto, EP | 1 |
| Aveyard, P; Coleman, T; Cooper, S; Leonardi-Bee, J; Vaz, LR | 1 |
| Chenoweth, MJ; Hamilton, DA; Hawk, LW; Heitjan, DF; Lerman, C; Mahoney, MC; Novalen, M; Tyndale, RF | 1 |
| Boulamery, A; Liachenko, N; Simon, N | 1 |
| Beatrice, F; Graziano, S; Massaro, G; Pacifici, R; Pellegrini, M; Pichini, S | 1 |
| Blazekovic, S; Gariti, P; Goelz, PM; Hitsman, B; Kaufmann, A; Leone, FT; Powers, L; Schnoll, RA; Tyndale, RF; Veluz-Wilkins, A | 1 |
| Hwang, SJ; Liu, KH | 1 |
| De Cremer, KA; De Smedt, T; Dendale, P; Nackaerts, K; Van Laethem, DM; Van Loco, J; Van Overmeire, IP; Vanacker, H; Vanoeteren, JF | 1 |
| Hatsukami, DK; Le, C; Li, ZZ; Mooney, ME; Murphy, SE; Pentel, PR | 1 |
| Ahluwalia, JS; Al Koudsi, N; Benowitz, NL; Ho, MK; Mwenifumbo, JC; Okuyemi, KS; Tyndale, RF | 1 |
| Ahluwalia, JS; Benowitz, NL; Bronars, CA; Choi, WS; Cox, LS; Faseru, B; Krebill, R; Mayo, MS; Nollen, NL; Okuyemi, KS; Salzman, GA; Snow, TS; Tyndale, RF | 1 |
| Hajek, P; McRobbie, H; West, O | 1 |
| Ansermot, N; Choong, E; Cornuz, J; Dobrinas, M; Eap, CB; Noetzli, M | 1 |
| Benowitz, NL; Gandhi, KK; Lu, SE; Steinberg, ML; Williams, JM | 1 |
| Huestis, MA; Scheidweiler, KB; Shakleya, DM | 1 |
| De Cremer, K; Van Loco, J; Van Overmeire, I | 1 |
| Benowitz, N; Lerman, C; Patterson, F; Pinto, A; Shields, PG; Tyndale, R; Wileyto, EP | 1 |
| Berlin, I; Gasior, MJ; Moolchan, ET | 1 |
| Benowitz, N; Jepson, C; Lee, AM; Lerman, C; Shields, PG; Tyndale, RF | 1 |
| Benowitz, NL; Jacob, P; Zevin, S | 1 |
| Anderson, R; Croghan, IT; Dale, LC; Hurt, RD; Ji, AJ; Lawson, GM | 1 |
2 review(s) available for hydroxycotinine and Smoking Cessation
| Article | Year |
|---|---|
The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.
Topics: Biomarkers; Cost-Benefit Analysis; Cotinine; Cytochrome P-450 CYP2A6; Electronic Nicotine Delivery Systems; Genetic Testing; Genetic Variation; Humans; Implementation Science; Metabolic Clearance Rate; Neoplasms; Nicotine; Precision Medicine; Prevalence; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence.
Topics: Cotinine; Humans; Nicotine; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2011 |
10 trial(s) available for hydroxycotinine and Smoking Cessation
| Article | Year |
|---|---|
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.
Topics: Cotinine; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Linear Models; Male; Middle Aged; Nicotine; Predictive Value of Tests; Smoking; Smoking Cessation; Tobacco Use Disorder | 2014 |
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
Topics: Adult; Biomarkers; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2015 |
The Nicotine Metabolite Ratio in Pregnancy Measured by trans-3'-Hydroxycotinine to Cotinine Ratio: Characteristics and Relationship With Smoking Cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Cotinine; Female; Humans; Middle Aged; Nicotine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2015 |
Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers.
Topics: Adult; Biomarkers; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Reproducibility of Results; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2015 |
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Black or African American; Body Mass Index; Cotinine; Cytochrome P-450 CYP2A6; Double-Blind Method; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Polymorphism, Genetic; Smoking Cessation | 2009 |
Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Black or African American; Bupropion; Cotinine; Counseling; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Female; Genotype; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Kansas; Male; Middle Aged; Motivation; Nicotine; Oxidoreductases, N-Demethylating; Patient Education as Topic; Patient Selection; Phenotype; Recurrence; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2011 |
Rapid smoking may not be aversive in schizophrenia.
Topics: Adult; Carbon Monoxide; Cotinine; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation | 2013 |
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Cotinine; Female; Humans; Liver; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2006 |
Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Analysis of Variance; Biological Availability; Cotinine; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Regression Analysis; Smoking; Smoking Cessation | 1997 |
A new gas chromatography-mass spectrometry method for simultaneous determination of total and free trans-3'-hydroxycotinine and cotinine in the urine of subjects receiving transdermal nicotine.
Topics: Administration, Cutaneous; Cotinine; Gas Chromatography-Mass Spectrometry; Humans; Nicotine; Nicotinic Agonists; Sensitivity and Specificity; Smoking; Smoking Cessation | 1999 |
14 other study(ies) available for hydroxycotinine and Smoking Cessation
| Article | Year |
|---|---|
Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations.
Topics: Adult; Black or African American; Black People; Cotinine; Cytochrome P-450 CYP2A6; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Pharmacogenomic Variants; Principal Component Analysis; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome; White People | 2021 |
Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy.
Topics: Adult; Cotinine; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Tobacco Products; Varenicline | 2017 |
Clinical significance of early smoking withdrawal effects and their relationships with nicotine metabolism: preliminary results from a pilot study.
Topics: Adult; Affect; Anxiety; Attention; Cotinine; Craving; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Nicotine and metabolites determination in human plasma by ultra performance liquid chromatography-tandem mass spectrometry: a simple approach for solving contamination problem and clinical application.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Biotransformation; Calibration; Charcoal; Chromatography, Liquid; Cotinine; Female; Humans; Liquid-Liquid Extraction; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reference Standards; Reproducibility of Results; Smoking Cessation; Tandem Mass Spectrometry; Tobacco Use Cessation Devices; Transdermal Patch; Young Adult | 2015 |
Successful Nicotine Intake in Medical Assisted Use of E-Cigarettes: A Pilot Study.
Topics: Adolescent; Adult; Biomarkers; Carbon Monoxide; Cotinine; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2015 |
Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Topics: Administration, Cutaneous; Analysis of Variance; Anxiety; Biomarkers; Cotinine; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Effect of smoking cessation for 1 year on periodontal biomarkers in gingival crevicular fluid.
Topics: Adult; Biomarkers; Cotinine; Dental Plaque Index; Enzyme-Linked Immunosorbent Assay; Female; Gingival Crevicular Fluid; Humans; Interleukin-1beta; Male; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Middle Aged; Nicotine; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontium; Prospective Studies; Saliva; Smoking; Smoking Cessation | 2016 |
Nicotine Dependence and Urinary Nicotine, Cotinine and Hydroxycotinine Levels in Daily Smokers.
Topics: Adolescent; Adult; Biomarkers; Cotinine; Female; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tandem Mass Spectrometry; Tobacco Use Disorder; Young Adult | 2016 |
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.
Topics: Adult; Aged; Analysis of Variance; Cotinine; Female; Humans; Linear Models; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 2008 |
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation.
Topics: Benzazepines; Chromatography, High Pressure Liquid; Cotinine; Drug Stability; Humans; Linear Models; Nicotine; Quinoxalines; Reproducibility of Results; Sensitivity and Specificity; Smoking Cessation; Tandem Mass Spectrometry; Varenicline | 2011 |
Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry.
Topics: Calibration; Chromatography, Liquid; Cotinine; Humans; Mecamylamine; Nicotine; Sensitivity and Specificity; Smoking; Smoking Cessation; Tandem Mass Spectrometry | 2012 |
On-line solid-phase extraction with ultra performance liquid chromatography and tandem mass spectrometry for the detection of nicotine, cotinine and trans-3'-hydroxycotinine in urine to strengthen human biomonitoring and smoking cessation studies.
Topics: Chromatography, Liquid; Cotinine; Environmental Exposure; Humans; Nicotine; Reproducibility of Results; Sensitivity and Specificity; Smoking; Smoking Cessation; Solid Phase Extraction; Tandem Mass Spectrometry; Tobacco Smoke Pollution | 2013 |
Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers.
Topics: Adolescent; Area Under Curve; Chromatography, Thin Layer; Cohort Studies; Contraceptives, Oral, Hormonal; Cotinine; Female; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation | 2007 |
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy.
Topics: Administration, Cutaneous; Administration, Inhalation; Aryl Hydrocarbon Hydroxylases; Cotinine; Cytochrome P-450 CYP2B6; Genotype; Humans; Linkage Disequilibrium; Nicotine; Nicotinic Agonists; Oxidoreductases, N-Demethylating; Smoking Cessation | 2007 |